Protection against experimental autoimmune encephalomyelitis requires both CD4+ T suppressor cells and myelin basic protein-primed B cells (Q67693900)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1712365%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

Protection against experimental autoimmune encephalomyelitis requires both CD4+ T suppressor cells and myelin basic protein-primed B cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1712365%20AND%20SRC:MED&resulttype=core&format=json

experimental autoimmune encephalomyelitis

17 September 2019

main subject

0 references

1 reference

https://api.crossref.org/works/10.1016/0165-5728(91)90061-B

5 November 2022

1 reference

https://api.crossref.org/works/10.1016/0165-5728(91)90061-B

5 November 2022

author name string

W. J. Karpus

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712365

5 November 2022

R. H. Swanborg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712365

5 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1712365

5 November 2022

publication date

1 August 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1712365%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

17 September 2019

https://api.elsevier.com/content/article/PII:016557289190061B?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0165-5728(91)90061-B

https://api.elsevier.com/content/article/PII:016557289190061B?httpAccept=text/plain

5 November 2022

1 reference

https://api.crossref.org/works/10.1016/0165-5728(91)90061-B

Journal of Neuroimmunology

5 November 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1712365%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1712365%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1712365%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

173-177

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1712365%20AND%20SRC:MED&resulttype=core&format=json

Evidence for suppressor cells in Lewis rats' experimental allergic encephalomyelitis

17 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0165-5728(91)90061-B

A suppressor T-lymphocyte cell line for autoimmune encephalomyelitis

5 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0165-5728(91)90061-B

Antibodies specific for VB8 receptor peptide suppress experimental autoimmune encephalomyelitis

5 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0165-5728(91)90061-B

CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-beta

5 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0165-5728(91)90061-B

Regulation of experimental allergic encephalomyelitis. Part 4. Further characterization of postrecovery suppressor cells

5 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0165-5728(91)90061-B

Antigen-specific inhibition of immune interferon production by suppressor cells of autoimmune encephalomyelitis

5 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0165-5728(91)90061-B

Protection from experimental allergic encephalomyelitis conferred by a monoclonal antibody directed against a shared idiotype on rat T cell receptors specific for myelin basic protein

5 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0165-5728(91)90061-B

Suppression of allergic encephalomyelitis in rats by means of antibrain serum

5 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0165-5728(91)90061-B

Long-term depletion of CD8+ T cells in vivo in the rat: no observed role for CD8+ (cytotoxic/suppressor) cells in the immunoregulation of experimental allergic encephalomyelitis

5 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0165-5728(91)90061-B

Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions.

5 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0165-5728(91)90061-B

Experimental allergic encephalomyelitis

5 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0165-5728(91)90061-B

Experimental allergic encephalomyelitis in the Lewis rat: studies on the mechanism of recovery from disease and acquired resistance to reinduction

5 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0165-5728(91)90061-B

Mechanisms of recovery and acquired resistance in Lewis rat experimental allergic encephalomyelitis.

5 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0165-5728(91)90061-B

Prevention and treatment of murine experimental allergic encephalomyelitis with T cell receptor V beta-specific antibodies

5 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0165-5728(91)90061-B

5 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1712365%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference